Literature DB >> 7945175

Immunological control mechanisms in plaque formation.

G K Hansson1.   

Abstract

Atherosclerosis is characterized by cholesterol accumulation, inflammation, and fibrous tissue formation. We have analyzed inflammatory components of atherosclerotic plaques and obtained evidence for T lymphocyte activation and cytokine secretion. A molecular genetical characterization of T cell clones obtained from atherosclerotic lesions revealed that the cells are heterogeneous with regard to antigen receptor gene organization. This indicates that they are derived from several progenitors and respond to different antigenic epitopes. The latter are not yet known, and it is also unclear to what extent the lymphocytic infiltrate in plaques represent a local immune response. Vascular effects of cytokines produced by plaque macrophages and lymphocytes were studied in cell culture and animal experiments. It was found that the T cell cytokine, interferon-gamma, inhibits cholesterol accumulation and foam cell formation by down-regulating the scavenger receptor on macrophages. It also inhibits smooth muscle proliferation in culture and the formation of arterial restenosis after angioplasty in experimental animals. Together, these studies emphasize the importance of vascular-immune interactions in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945175     DOI: 10.1007/978-3-642-85660-0_4

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  10 in total

Review 1.  Immunology of atherosclerosis: the promise of mouse models.

Authors:  A H Lichtman; M Cybulsky; F W Luscinskas
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

2.  Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis.

Authors:  Sudesh Agrawal; Munna L Agarwal; Moitreyee Chatterjee-Kishore; George R Stark; Guy M Chisolm
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 3.  Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson.

Authors:  Yong-Jian Geng; Lena Jonasson
Journal:  Vascul Pharmacol       Date:  2011-11-20       Impact factor: 5.773

4.  Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.

Authors:  X Zhou; G Paulsson; S Stemme; G K Hansson
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury.

Authors:  L Liu; A Lalani; E Dai; B Seet; C Macauley; R Singh; L Fan; G McFadden; A Lucas
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 6.  The mechanisms of coronary restenosis: insights from experimental models.

Authors:  G A Ferns; T Y Avades
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

7.  Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Tanja K Rudolph; Volker Rudolph; Martin M Edreira; Marsha P Cole; Gustavo Bonacci; Francisco J Schopfer; Steven R Woodcock; Andreas Franek; Michaela Pekarova; Nicholas K H Khoo; Alyssa H Hasty; Stephan Baldus; Bruce A Freeman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-18       Impact factor: 8.311

8.  Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory.

Authors:  Hamidreza Honarmand
Journal:  Interdiscip Perspect Infect Dis       Date:  2013-07-17

Review 9.  Cardiovascular Effects Mediated by HMMR and CD44.

Authors:  Kinga Jaskuła; Mariusz Sacharczuk; Zbigniew Gaciong; Dominik S Skiba
Journal:  Mediators Inflamm       Date:  2021-07-10       Impact factor: 4.711

10.  Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival.

Authors:  Ling Wang; Shamit K Dutta; Tatsuyoshi Kojima; Xiaolei Xu; Roya Khosravi-Far; Stephen C Ekker; Debabrata Mukhopadhyay
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.